Medical Xpress March 23, 2023
By University of Eastern Finland

First-in-human clinical trials have been initiated at Kuopio University Hospital with a device that assists in the identification of cancerous tissue during surgery. The tissue monitoring technique developed by startup company Marginum is based on the interdisciplinary research of the University of Eastern Finland, Kuopio University Hospital Neurosurgery and the Eastern Finland Microsurgery Center.

It is the first time such a tissue recognition technology is brought into the operating theater. “Our goal is to refine the technique into a golden standard for fluorescence-guided surgery,” says Adjunct Professor of Experimental Neurosurgery and Marginum’s Chairman of the Board Antti-Pekka Elomaa.

The aspirate tissue monitor is attached to a surgical suction tube routinely used in the operation, through which the tissue is removed....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Medical Devices, Provider, Trends
Bruker to acquire Nanostring for $393M
Abbott's gains in medical device sales push quarterly haul to nearly $10B
Abbott looks to ‘highly productive’ device pipeline for future growth
Scopio Labs Receives FDA Clearance For AI-Driven Bone Marrow Analysis Application
10 notes on colonoscopies in 2024

Share This Article